- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-3305
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prophylactic and therapeutic DNA vaccines against Chagas disease ; volume:8 ; number:1 ; day:24 ; month:2 ; year:2015 ; pages:1-7 ; date:12.2015
Parasites & vectors ; 8, Heft 1 (24.2.2015), 1-7, 12.2015
- Urheber
-
Arce-Fonseca, Minerva
Rios-Castro, Martha
Carrillo-Sánchez, Silvia del Carmen
Martínez-Cruz, Mariana
Rodríguez-Morales, Olivia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13071-015-0738-0
- URN
-
urn:nbn:de:101:1-2021082020301020050434
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arce-Fonseca, Minerva
- Rios-Castro, Martha
- Carrillo-Sánchez, Silvia del Carmen
- Martínez-Cruz, Mariana
- Rodríguez-Morales, Olivia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of prophylactic vaccines against HIV-1
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
Development of prophylactic and therapeutic combined vaccines against human papillomaviruses (HPV) using a multimerized thioredoxin (Trx) scaffold
Vaccines against allergies
Nanomedicines against Chagas disease: a critical review
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Prophylactic vaccines for patients with human papillomavirus diseases (HPV)
Chagas
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Long term cellular immune response to prophylactic human papillomavirus (HPV) vaccines
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Development of a novel vaccination strategy against Chagas disease
Development of prophylactic vaccines against HIV-1
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
Development of prophylactic and therapeutic combined vaccines against human papillomaviruses (HPV) using a multimerized thioredoxin (Trx) scaffold
Vaccines against allergies
Nanomedicines against Chagas disease: a critical review
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Prophylactic vaccines for patients with human papillomavirus diseases (HPV)
Chagas
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Long term cellular immune response to prophylactic human papillomavirus (HPV) vaccines
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Development of a novel vaccination strategy against Chagas disease
Development of prophylactic vaccines against HIV-1
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
Development of prophylactic and therapeutic combined vaccines against human papillomaviruses (HPV) using a multimerized thioredoxin (Trx) scaffold
Vaccines against allergies
Nanomedicines against Chagas disease: a critical review
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Prophylactic vaccines for patients with human papillomavirus diseases (HPV)
Chagas
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans
Long term cellular immune response to prophylactic human papillomavirus (HPV) vaccines
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines